Subscribe to Our Free Newsletter!
the "Breathe Easy" News
Name
Email
More info
How to Learn to Live Without Asthma
Seminars and Classes | Teacher Training | Home Video Education Kit
along with a Medical professional packet with clinical trial information you can share with your physician.
 
  The Kick Asthma™ program – an effective natural health treatment based on the Buteyko method. Treat asthma, sinusitus, snoring, sleep apnea, breathing disorders. Control symptoms and reduce medication with Kick Asthma™.











 


The Buteyko Method Research

Buteyko Clinical Trials
Buteyko Breathing Techniques in Asthma: A blinded randomized controlled trial (Medical Journal of Australia, Dec 1998)
Prevalence of dysfunctional breathing in patients treated for asthma in primary care: a cross sectional survey (British Medical Journal, May 2001)
Gisborne Hospital New Zealand: To find out if the Buteyko Institute Method can: reduce intake of beta-agonists, reduce intake of inhaled steroids, reduce the incidence of asthma attacks, improve the quality of life of asthmatics.
Glasgow Scotland: Buteyko Trial shows drop in asthma medication use, Rada Rouse
Other Buteyko studies

Buteyko Breathing Techniques in Asthma: a blinded randomized controlled trial
Simon D Bowler, Amanda Green and Charles A Mitchell
Medical Journal of Australia 1998; 169: 575-578
http://www.mja.com.au/

Summary
Objective: To evaluate the effect of Buteyko breathing techniques in the management of asthma.

Design: Prospective, blinded, randomized study comparing the effect of Buteyko breathing techniques with control classes in 39 people with asthma. The study was conducted from January 1995 to April 1995.

Participants: Subjects recruited from the community, aged 12 to 70 years, with asthma and substantial medication usage.

Results after applying Buteyko techniques for twelve weeks:
Reliever usage - median reduction of 96% (from daily median of 943ug to 39ug)
Preventer usage - median reduction of 49% (from daily median 1500ug to 765ug)
Minute Volume - median reduction of 4.6L/min (from 14 L/min to 9.6 L/min)
The relative reduction in reliever medication use in the Buteyko group was related to the proportionate reduction in minute volume. (r=0.51; P=0.04)
Results after applying placebo breathing techniques - Control group:
Reliever usage - median reduction of 5% (from daily median of 843ug to 801ug)
Preventer usage - no median reduction
Minute Volume - median reduction of 0.9L/min (from 14.2 L/min to 13.3 L/min)

Conclusion: Those practicing Buteyko breathing techniques reduced hyperventilation and their use of reliever medications (beta2-agonists ) and preventers (inhaled steroids). Participants in the Buteyko group showed improved scores for Quality of Life whilst the Control group saw no significant improvements in either hyperventilation, medication usage or Quality of Life.

[return to top]


Prevalence of dysfunctional breathing in patients treated for asthma in primary care: a cross sectional survey
M Thomas, RK McKinley, E Freeman, C Foy
British Medical Journal 2001;322:1098-1100 (5 May)

Summary

Objectives: To estimate the prevalence of dysfunctional breathing in adults with asthma treated in the community.

Design: Postal questionnaire survey using Nijmegen questionnaire

Setting: One general practice with 7033 patients.

Participants: All adult patients aged 17-65 with diagnosed asthma who were receiving treatment.

Main outcome score: Score greater than or equal to 23 or Nijmegen questionnaire.

Results
227/307 patients returned completed questionnaires; 219 (71.3%) questionnaires were suitable for analysis.
63 participants scored greater than or equal to 23. Those scoring greater than or equal to 23 were more likely to be female than male (46/132 (35%) v 17/87 (20%), P=0.016) and were younger (mean (SD) age 44.8 (14.7) v 49.0 (13.8), P=0.05).
Patients at different treatment steps of the British Thoracic Society guidelines were affected equally.

Conclusions: About a third of women and a fifth of men had scores suggestive of dysfunctional breathing. Although further studies are needed to confirm the validity of this screening tool and these findings, these prevalence suggest scope for therapeutic intervention and may explain the anecdotal success of the Buteyko method of treating asthma.

[Return to top]


Gisborne Hospital New Zealand

Dr Patrick Mc Hugh BMed Sc, MBChB, Dip GUMed, Dip MSM
DR Fergus Aitcheson BHB, MBChB, FRACP - Director Medicine Gisborne Hospital
Ms Liz Buckley RNOG, BA - Gisborne Hospital Asthma Educator
DR Dennis Butcher MD - Consultant Physician

Buteyko Institute Method Techniques for Controlling Asthma

Commencement date: 6.3.2000 Testing completed September 2000

Study Goals: To find out if the Buteyko Institute Method can:
reduce intake of beta-agonists
reduce intake of inhaled steroids
reduce the incidence of asthma attacks
improve the quality of life of asthmatics

Design: A randomized, double blind trial, with the Buteyko group learning the Buteyko Institute Method as taught by Buteyko New Zealand.
The control group were instructed by the Tairawhiti Healthcare LTD's asthma educator with the standard accepted asthma education, i.e. inhaler technique, peak expiratory flow monitoring with action plans, anatomy, physiology, trigger factors and warning signs and other breathing techniques not involving reduction of hyperventilation.

Participants: Forty participants were selected for inclusion and were matched and randomly assigned to either Buteyko or control groups.

Inclusion Criteria:
Aged between 18 and 70
Diagnosed by GP as asthmatic with history of variable difficulty in breathing with wheeze or chest tightness and an improvement with Beta 2 agonist
Use of significant medication for asthma. At least 1400ug of short acting beta agonist or equivalent long-acting beta 2 agonist over the last week of the run-in period
Exclusion Criteria:
A recent change in inhaled steroid dose or use or oral steroid during the 4 weeks prior to the run in period
Previous instruction in the Buteyko Method

The trial: included seven sessions of instruction. Four sessions in the first week, two sessions in the second week and one session in the third week.

Evaluation:
Diary cards were kept to record:
night and morning PEF(Peak Expiratory Flow) readings (beginning at the end of first teaching week)
symptom scores
daily beta agonist dose and other medications
Clinical Visits:
lung function as measured by forced expiration
Quality of Life index (after Marks)
number of exacerbations

At three months and again at six months, testing of FEV1, ETCO2 and QOL measurements were carried out for both groups.

Results: results are currently being analyzed and report compiled.

An interim report, regarding this trial, was delivered by DR Patrick McHugh to the delegates of the BIBH International Conference, Hastings New Zealand December 2000.

[Return to top]


Other Studies

Hamilton Polytechnic, New Zealand, pilot study, 1999

Victoria University, Victoria Australia. (Cameron Gosling, Steve Lee). BIBH (Paul O'Connell), 1999

This information provided courtesy of the Buteyko Institute of Breathing and Health (BIBH).

[Buteyko Method] [Buteyko Research] [Buteyko Articles]

 

 


Home
| About Us | Contact Us | Testimonials | Links
The Buteyko Method | Asthma Information | Article Archives
Shop | Learn Kick Asthma | Special Events | Members
Seminars & Classes | Teacher Training | Home Video Education Kit
 

Kick Asthma®, LLC
4701 SW Admiral Way
Suite 167

Seattle, WA 98116

Tel 206-763-8882
info@kickasthma.com

The information and techniques presented on this website do not constitute medical treatment. You should consult your health care provider before trying the techniques presented on this site and before modifying any medication prescribed to you. Kick Asthma®, LLC makes no guarantees or warranties about results you may experience as a result of the techniques presented on this website or in products sold from this website. Kick Asthma®, LLC is not liable or responsible for any damage caused or alleged to be caused, either directly or indirectly, by the information contained on this website or products for sale on this website.
 

© Copyright 2000-2006, Kick Asthma®, LLC. All rights reserved.

Website development by New Tech Web, Inc.

 

Click here to get your FREE e-book

 

 

 


Learn the Buteyko Method at home
Learn Buteyko at Home!